1. China Stocks

  2. •

    Producer manufacturing

  3. •

    Industrial machinery
Morimatsu International Holdings Company Limited

Morimatsu International Holdings Company Limited

0.96
EUR
+0.02
(+2.14%)
1.21BMarket Cap
Apr 01Next Earn
Morimatsu International Holdings Company Limited
FRA:1S5
(Frankfurt Stock Exchange)

Recent

price

0.96

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
1.57
2.47
2.83
2.98
4.79
6.17
6.33
5.83
5.7
- -
Revenue per Share
0.01
0.12
0.15
0.29
0.43
0.64
0.73
0.62
0.49
- -
Basic EPS, GAAP
0.34
0.2
0.07
0.03
0.82
0.01
0.09
0.61
0.06
- -
Free Cash Flow per Basic Share
0.01
0.15
- -
- -
0.03
- -
- -
0.09
0.14
- -
Dividend per Share
1.41
1.07
0.71
1
1.94
2.62
3.68
4.14
4.5
4.5
Book Value per Share
1.22
0.89
0.58
0.86
1.8
2.43
3.51
3.95
4.19
4.19
Tangible Book Value per Share
1,000
1,000
1,000
1,000
895
1,051
1,163
1,191
1,220
1,245
Basic Weighted Avg Shares
1,570
2,468
2,826
2,979
4,286
6,486
7,360
6,948
6,955
- -
Sales/Revenue/Turnover
1.42
5.73
5.94
12.7
11.1
12.11
12.88
11.94
9.48
- -
Operating Margin (%)
88
88
83
77
93
114
145
195
238
- -
Depreciation Expense
7
116
149
289
382
669
845
737
600
- -
Net Income, GAAP
49.66
17.67
15.11
15.24
14.99
12.45
14.4
19.9
18.51
- -
Effective Tax Rate (%)
0.45
4.71
5.28
9.72
8.91
10.32
11.48
10.61
8.62
- -
Profit Margin (%)
136
218
-212
22
620
955
2,123
2,701
3,169
3,169
Working Capital
4
380
16
2
2
207
194
181
44
44
LT Debt
1,438
1,110
707
998
2,008
2,823
4,391
5,276
5,858
5,858
Total Equity
- -
9.06
10.31
22.64
20.54
23.29
20.76
14.01
9.93
- -
Return on Invested Capital (%)
- -
6.72
11.16
22.86
20.97
24.2
21.28
14.55
10.61
- -
Return on Capital (%)
- -
9.39
16.79
33.94
25.4
27.75
23.47
15.63
11.26
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
115
172
373
LT Borrowings
126
81
- -
LT Finance Leases
54
52
44
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,220
1,245
1,245
Market Capitalization
4,957
6,729
9,981

Working Capital

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
6,079
6,714
6,982
Cash, Cash Equivalents & STI
2,992
3,174
3,284
Accounts Receivable, Net
1,036
948
971
Inventories
797
1,023
730
Total Current Liabilities
3,378
3,948
3,812
Payables & Accruals
- -
- -
- -
ST Debt
115
172
373
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
45.69%
11.04%
Free Cash Flow
- -
742.35%
-89.15%
Net Income, GAAP
- -
20.41%
-18.67%
Sales/Revenue/Turnover
- -
20.64%
0.09%
Total Cash Common Dividend
- -
- -
53.84%

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
7,360
2024
- -
- -
6,948
2025
- -
- -
6,955

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.73
2024
- -
- -
0.62
2025
- -
- -
0.49

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
0.09
2025
- -
- -
0.14
Similar Companies
Applied Materials, Inc. (NASDAQ:AMAT)
Oklo Inc. (NYSE:OKLO)
Lam Research Corporation (NASDAQ:LRCX)
Tokyo Electron Ltd. (TSE:8035)
Welspun Corp Limited (NSE:WELCORP)
Symbotic Inc. (NASDAQ:SYM)
Business
Morimatsu International Holdings Company Limited manufactures pressure equipment and provides integrated solutions for core process equipment, process systems, and engineering projects serving industries including oil and gas refining, pharmaceuticals, biopharmaceuticals, new chemical materials, power battery raw materials, electronic chemicals, and fast-moving consumer goods; its core products encompass traditional pressure vessels such as heat exchangers, tanks, reactors, and towers, alongside modular equipment including process modules, skids, modular factories, bioreactor systems, fermenters, parallel bioreactors, biodownstream systems, ultrafiltration systems, inline buffer dilution systems, preparation systems, CIPS workstations, sanitary tanks, wet granulators, multifunctional fluidized beds, filter washing dryers, crystallizing tanks, disposable bag storages, multifunctional utility panels, and data centers; the company also delivers value-added services comprising design, validation, installation, operation, maintenance, biotechnology consulting, structural and special equipment design, engineering cost consultancy, and technical support. Founded in 1990 and headquartered at No. 29 Jinwen Road, Zhuqiao Town, Pudong New District, Shanghai, China, Morimatsu operates globally with approximately 4,500 employees across domestic and international markets, including subsidiaries focused on biopharmaceutical solutions and high-purity chemical equipment. In recent developments, the company completed the acquisition of Bioengineering AG on September 10, 2025, enhancing its biopharmaceutical capabilities with advanced modular plant solutions and process equipment expertise; it earned Samsung E&A's "Supplier of the Year" award for the third time in September 2025, underscoring a decade-long partnership; and established a new wholly-owned subsidiary in March 2024 to support ongoing expansions.